Whether smooth legs or hairless armpits - it's nothing new for women to repeatedly reach for the blade to get rid of unwanted hair. But now - according to a current skincare trend - the face should be ...

Summer may be over but sun protection is an all-year event, and that’s why a nonprofit organization is bringing free skin cancer screenings to New Yorkers next week. Starting Thursday, Sept. 26, New ...

Rosacea is a chronic inflammatory skin condition that is tricky to treat and requires a medical diagnosis. The intensity of ...

Raritan: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved RYBREVANT (amivantamab ...

Rybrevant (amivantamab-vmjw) in combination with standard-of-care chemotherapy (carboplatin and pemetrexed) for locally ...

Endocytosis and recycling control the uptake and retrieval of various materials in eukaryotic cells. Mammalian cells have ...

Approvals are coming fast and furious for Johnson & Johnson’s Rybrevant as it is lining up to challenge the dominance of ...

The FDA approval of amivantamab-vmjw (Rybrevant) in combination with chemotherapy is the first targeted treatment to cut ...

The US Food and Drug Administration yesterday approved a new indication for Rybrevant (amivantamab-vmjw), from Johnson & ...

South Korean pharmaceutical giant Yuhan announced Friday it has terminated its collaboration with Janssen Biotech on the ...

Johnson & Johnson (JNJ) announced that the U.S. Food and Drug Administration approved RYBREVANT (amivantamab-vmjw) in combination ...

"With Rybrevant-based regimens, we are bringing potential new standards of care to the nearly 30,000 patients diagnosed with epidermal growth factor receptor-mutated non-small cell lung cancer in the ...